web analytics
4.6 C
Munich
Sunday, April 18, 2021

Cryometrix S-90 Blast Freezer; the Rise of Reflect Scientific, Inc. (OTCMKTS: RSCF)

Reflect Scientific, Inc. (OTCMKTS: RSCF) is making a powerful move up the charts from a start point of $0.03 in recent months the stock has seen a rise to over $0.40 highs as penny stock speculators continue to accumulate.

Reflect has developed ultra-low temperature blast freezers; Cryometrix S-90 which allows for shipping at a controlled temperature between +20°C down to -90°C with a uniformity of ± 3°C and can be used in multiple industries for the storage and fast freezing profiles of everything from blood to vaccines. The Cryometrix S-90 could help in the global fight against coronavirus as Vaccine storage issues could leave 3B people without access as the vaccine needs non-stop sterile refrigeration to stay potent and safe.

Reflect Scientific, Inc. (OTCMKTS: RSCF) based in Orem, Utah, the company develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses.

Reflect’s Cryometrix brand ultra-low temperature and blast freezers innovative design enables its customers to save substantially on energy costs related to cryogenic storage. Ultra-low temperature freezers are used worldwide for the storage of vaccines, DNA, RNA, proteins and many other biological and chemical samples. There is a growing need for energy efficient, reliable ultra-low temperature storage units. Reflect’s Cryometrix freezers are targeted to this growing market and we have had tremendous success in blood storage and pharmaceutical manufacturing applications.  The application of this technology for use in refrigerated trailers  used to transport goods which need to be maintained in a cold environment significantly broadens the market for this technology.  The utilization of this technology in reefers eliminates the current method of cooling, which utilize engines run on hydrocarbon fuels.  The Cryometrix technology is pollutant free and is more cost effective and efficient than the technologies currently used. Reflect has added a new product line of solvent chillers.  Solvent chillers are used in natural products extraction for optimizing product yield.

Reflect’s Cryometrix ultra low temperature and blast freezers are, the Company believes, a technological breakthrough that provides energy savings and other critically important benefits to cryo-storage customers in the Life Science related industries.  Ultra-low temperature and blast freezers are used in multiple industries for the storage and fast freezing profiles of everything from blood to cancer vaccines.  These types of freezers are used by hospitals and biotechnology research facilities.

To Find out the inside Scoop on RSCF Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RSCF

Reflect’s blast freezers could help in the global fight against coronavirus as Vaccine storage issues could leave 3B people without access. According to a recent AP article “From factory to syringe, the world’s most promising coronavirus vaccine candidates need non-stop sterile refrigeration to stay potent and safe. But despite enormous strides in equipping developing countries to maintain the vaccine “cold chain,” nearly 3 billion of the world’s 7.8 billion people live where temperature-controlled storage is insufficient for an immunization campaign to bring COVID-19 under control.”

On October 19 RSCF announced a recently awarded patent for a cryogenic modular shipping unit that can reliably and uniformly maintain its payload at temperatures as low as -90 degrees Celsius, making it an ideal system for cold chain management of biologics like COVID 19 vaccines. The cryogenic system provides the customer with a capability of short or long duration bulk shipping and may also be used for long term storage.

The commercially available Cryometrix S-90 shipping system eliminates managing loads of dry ice, waiting hours for the temperature to saturate the shipping container, and having little to no control over the products’ temperature during shipping. The Cryometrix S-90 bundles innovative upright liquid nitrogen freezer technology with an onboard liquid nitrogen tank and power supply. You can ship up to 33.5 cubic feet of product (or 70,000 vials) at a controlled temperature between +20°C down to -90°C with a uniformity of ± 3°C.

We have a Monster Pick Coming. Subscribe Right Now!

Currently on the rise RSCF is an exciting story developing in small caps; Reflect has develped ultra low temperature blast freezers; Cryometrix S-90 which allows for shipping at a controled tamperature between +20°C down to -90°C with a uniformity of ± 3°C and can be used in multiple industries for the storage and fast freezing profiles of everything from blood to vaccines. The Cryometrix S-90 could help in the global fight against coronavirus as Vaccine storage issues could leave 3B people without access as the vaccine needs non-stop sterile refrigeration to stay potent and safe. We will be updating on RSCF when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with RSCF.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in RSCF either long or short and we have not been compensated for this article.

 

 

More articles

2 COMMENTS

  1. Boe Rimes

    I just found this post..Thanks for all the great information.. good thing it was in the morning..I bought at .30…

    Looks like others must have found it also..RSCF closed at .81 today (12/2)..

    Here is to a good Christmas..

    Dan

  2. I live in Salt Lake and recently visited their plant. Seems like they have a very seasoned management team and I know the CFO personally. I think the demand is huge. My only concern is will they be able to scale quickly, They now have a $200 mill market cap, and its hard to justify for me, the current price of $2.35. My guess it will run to at least $5.00 in the next few months. And if they sign a deal with the Govt. then there is no stopping it.
    I bought in back in March, when i first heard about it, and got it at .03 cents. Since then I have sold all those shares to recover my initial investment. Now playing with the house money. Still have 25001 shares left.
    Ez dude

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.